维普中文期刊产品整合服务
33篇 您的检索式:作者名="Boukovinas"
    题名 作者 年代 出处 被引量
1A nmlticenter ran- domized phase :I trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline-and taxane-pretreated women with metastatic breast cancer显示文摘Pallis AG Boukovinas I Ardavanis A 2012Ann Oncol2012,23,5:1
2Tumor BRCA1, RRM1 and RRbI2 mRNA expression levels and clinical re- sponse to first-line gemcitabine plus docetaxel in non-small- cell lung cancer patients 显示文摘Boukovinas I Papadaki C Mendez P 2008PLoS One2008,3,11:1
3Tumor BRCA1,RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients显示文摘Boukovinas I Papadaki C Mendez P 2008PLoS ONE2008,3,11:1
4Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine显示文摘Souglakos J Boukovinas I Taxon M 2008Br J Cancer2008,98,10:1
5Tumor BRCA1,RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients 显示文摘Boukovinas I Papadaki C Mendez P 2008PLoS One2008,3,11:1
6Sequentialgemcitabine and cisplatin followed by docetaxel as first-linetreatment of advanced urothelial carcinoma:a multicenter phaseII study of the hellenic oncology research group显示文摘Boukovinas I Androulakis N Vamvakas L 2006Ann On-col2006,17,:1
7Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcin-oma patients treated with docetaxel/gemcitabine显示文摘Souglakos J Boukovinas I Taron M 2008Br J Cancer2008,98,10:1
8Ribonucleotide redue- tase subunits M1 and M2 mRNA expression levels and clinical out- come of lung adenoearcinoma patients treated with docetaxel/gem- eitabine显示文摘Souglakos J Boukovinas I Taron M 2008Br J Cancer2008,98,10:1
9Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first- line gemcitabine plus docetaxel in non-small-cell lung cancer patients显示文摘Boukovinas I Papadaki C Mendez P 2008PLoS One2008,3,11:1
10Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients 显示文摘Boukovinas I Papadaki C Mendez P 2008PLoS One2008,3,11:1
11Tumor BRCA1,RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-smallcell lung cancer patients显示文摘Boukovinas I Papadaki C Mendez P 0,,11:1
12Treatment of non-small cell lung cancer patients with performance status2(PS2)显示文摘Boukovinas I Kosmidis P 2009Lung Cancer2009,63,11:1
13Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to First-Line gemcitabine plus docetaxel in Non-Small-Cell lung cancer patients 显示文摘Boukovinas L Papadaki C Mendez P 2008PLoS ONE2008,3,11:1
14Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxeL/gemcitsbine 显示文摘Souqlakos J Boukovinas I Taron M 2008Br J Cancer2008,98,10:1
15A multicenter ran-domized phase III trial of vinorelbine/gemcitabine doublet versuscapecitabine monotherapy in anthracycline-and taxane-pretreatedwomen with metastatic breast cancer显示文摘Pallis AG Boukovinas I Ardavanis A et al 2012Ann Oncol2012,23,5:1
16Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase Ⅱ randomized trial 显示文摘 Mylonakis N Nicolaides C Kalophonos C Samantas E Boukovinas J Foutzilas G Skalos D Economopoulos T Tsavdaridis D Papakostas P Bacoyiannis C Dimopoulos 2002J Clin Oncol2002,20,17:1
17Ribonucleotide reductase subunits MI and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine 显示文摘Souglakos J Boukovinas I Taron M 2008Br J Cancer2008,98,10:1
18A multicenter randomized phase Ⅲ trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline-and taxane-pretreated women with metastatic breast cancer显示文摘Pallis AG Boukovinas I Ardavanis A 2012Ann Oncol2012,23,5:1
19Docetaxel plus gemciabineas frontline chemotherapy in elderly patients with lung adenocarcinomas:A multicenter phase II study 显示文摘Boukovinas I Soug lakos J Hatzidaki D 2008Lung Cancer2008,63,1:1
20RibonucIeotide reduc- tase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxelf gemcitabine显示文摘J Souglkos I Boukovinas M Talon 2008Br J Cancer2008,98,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费